Get the Stockscreener App
0.9419
1.27%
0.0118
Aptorum Group Ltd stock is traded at $0.9419, with a volume of 32,358.
It is up +1.27% in the last 24 hours and down -13.59% over the past month.
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
See More
Previous Close:
$0.93
Open:
$0.9302
24h Volume:
32,358
Relative Volume:
0.41
Market Cap:
$7.64M
Revenue:
$1.20M
Net Income/Loss:
$-2.82M
P/E Ratio:
-1.5191
EPS:
-0.62
Net Cash Flow:
$-7.73M
1W Performance:
-1.89%
1M Performance:
-13.59%
6M Performance:
-32.24%
1Y Performance:
-76.69%
1-Day Range:
$0.913
$0.949
1-Week Range:
$0.86
$0.9597
52-Week Range:
$0.46
$7.4899
Aptorum Group Ltd Stock (APM) Company Profile
Compare APM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APM
Aptorum Group Ltd
|
0.9419 | 7.64M | 1.20M | -2.82M | -7.73M | -0.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.85 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.94 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.24 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
250.30 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Aptorum Group Ltd Stock (APM) Latest News
Aptorum Group Limited (NASDAQ:APM) Short Interest Update - Defense World
Nasdaq Biggest Companies Featuring Aptorum Group Limited Kalkine - Kalkine Media
Aptorum Group (NASDAQ:APM) Shares Down 3.4% – Here’s What Happened - Defense World
Short Interest in Aptorum Group Limited (NASDAQ:APM) Expands By 122.0% - Defense World
Metrics That Matter About Aptorum Group Ltd (NASDAQ: APM) - stocksregister.com
Aptorum Group faces Nasdaq minimum bid price warning - Investing.com Australia
Aptorum Group faces Nasdaq minimum bid price warning By Investing.com - Investing.com India
Aptorum Group faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa
Aptorum Group faces Nasdaq delisting over share price - Investing.com Australia
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price - Bluefield Daily Telegraph
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - marketscreener.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Aptorum Group Limited (NASDAQ:APM) Sees Significant Decrease in Short Interest - Defense World
Head to Head Contrast: Spyre Therapeutics (NASDAQ:SYRE) & Aptorum Group (NASDAQ:APM) - Defense World
Aptorum Group Announces Completion of $3 Million Convertible Note due 2023 - Business Wire
Aptorum Gr Stock Price, Quotes and Forecasts | NASDAQ:APM - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Short Interest in Aptorum Group Limited (NASDAQ:APM) Declines By 57.4% - Armenian Reporter
Short Interest in Aptorum Group Limited (NASDAQ:APM) Rises By 1,564.9% - Defense World
Aptorum Group Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) - ACCESS Newswire
Aptorum Group Stock Soars by 270% Amid Positive Earnings Report and Strategic Shifts – Market - HPBL
Aptorum Group Secures $3 Million in Registered Direct Offering to Fuel Biopharmaceutical Advancements - HPBL
Aptorum Group to Issue 1.5 Million Class A Shares - Yahoo Finance
Aptorum announces pricing of $3M registered direct offering; shares drop - MSN
Aptorum Group Limited Announces Pricing of $3.0 Million Registered Direct Offering - Business Upturn
Wall Street Today: US stocks open higher after markets reopen post New Year; Tesla shares down 7% on low delivery data - Mint
Market Downturn: Which Stocks Resiliently Rose? Discover Now! - Reporteros del Sur -
Why Aptorum Group (APM) Jumped Nearly 300% at Pre-Market Trading - MSN
Stock market today: Aptorum Group +271.96%, VerifyMe +164.59% among top gainers in early trading - Business Upturn
US Stocks Open Higher; House Prices Increase In October - Benzinga
Aptorum Group Ltd.: Directors (Cayman Islands) - OffshoreAlert
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2024 - Business Wire
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket - Benzinga
Aptorum Group announces annual shareholder meeting details By Investing.com - Investing.com Australia
symbol__ Stock Quote Price and Forecast - CNN
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Markets Insider
Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy Business - Business Wire
Aptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Markets - Business Wire
Aptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths Innovations Limited - Business Wire
Aptorum Group Enters into Letter of Intent and Term Sheet To Acquire U Group - Business Wire
Aptorum Group Announces Completion of Pre-IND Discussions with US FDA on its ALS-4, a First-in-Class Small Molecule Drug Targeting Methicillin Resistant Staphylococcus Aureus - Business Wire
Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in China - Business Wire
Aptorum Group Announces 1-for-10 Reverse Stock Split - citybiz
Aptorum Group Limited Announces Results of 2022 Annual General Meeting of Shareholders - Business Wire
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2022 - Business Wire
Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in Hong Kong - Business Wire
Aptorum Group Limited to Present at the H.C. Wainwright Global Investment Conference, May 23 – 26 2022 - Business Wire
The Best Biotech Penny Stocks under $5 to Buy Right Now - AskTraders
Aptorum Shares Move Higher After Interim Data From Staphylococcus Aureus Candidate - Yahoo Finance
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance
Aptorum Group Announces Closing of $9.0 Million Public Offering - Business Wire
Aptorum Group Ltd Stock (APM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.10%
1.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):